α7 nAChRs themselves have been suggested as drug targets for various neurological disorders such as schizophrenia and Alzheimer’s disease, and several clinically tested modulators of the receptor have been developed54. The gene discussed is CHRNA7; the disease is early-onset autosomal dominant Alzheimer disease.